ASX Announcement – 19 November 2026 CHAIRPERSON’S ADDRESS & MANAGING DIRECTOR’S ADDRESS TO SHAREHOLDERS 2026 ANNUAL GENERAL MEETING Resonance Health Limited (ASX: RHT) (Resonance or Company) provides the addresses to be delivered by its Chairperson, Mr Aaron Brinkworth, and its Managing...
2026 AGM - Chair Address & MD/CEO Address to Shareholders
Filed with ASX · · 9 pages · English
Summary by 6ix AI
The Chairperson highlighted significant growth in revenue and a return to profitability, emphasizing the company's strategic progress and operational cash flow. The Managing Director discussed the company's performance, including revenue growth and the importance of upcoming trials and product developments. The filing also outlines the approval of a capital placement to fund new initiatives and enhance the company's market position.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Resonance Health
- Change in Substantial Holding
- MRI Muscle Endpoint - Product Update
- Alteration to Notice of Meeting
- Cleansing Notice
- Application for quotation of securities - RHT
Later from Resonance Health
All Resonance Health news releasesFollow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health